Brain Microischemic Phenomena in a Woman Receiving Bevacizumab Treatment
Author Information
Author(s): Quattrocchi Carlo C, Alexandre Andrea M, Tonini Giuseppe, Errante Yuri, Grasso Rosario F, Zobel Bruno Beomonte
Primary Institution: University Campus Bio-Medico of Rome
Hypothesis
What are the implications of focal neurological symptoms in patients receiving bevacizumab treatment?
Conclusion
The differential diagnosis in patients with cancer undergoing bevacizumab treatment should include microischemic phenomena.
Supporting Evidence
- Focal neurological symptoms can indicate serious complications in patients receiving bevacizumab.
- Brain MRI showed lesions suggestive of acute microischemic phenomena.
- The patient had no other risk factors for thromboembolic events.
Takeaway
This study talks about a woman who had brain issues while getting treatment for cancer, showing that doctors need to check for specific brain problems when patients have symptoms.
Methodology
Case report detailing the patient's medical history, treatment, and MRI findings.
Limitations
The findings are based on a single case, limiting generalizability.
Participant Demographics
37-year-old Italian Caucasian woman with metastatic colon cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website